Stromal-derived factor-1 delivered via hydrogel drug-delivery vehicle accelerates wound healing in vivo

Wound Repair and Regeneration

Volumn 19, Issue 3, 2011, Pages 420-425

  Henderson, Peter W ^a   Singh, Sunil P ^a   Krijgh, David D ^a   Yamamoto, Masaya ^b   Rafii, Daniel C ^b   Sung, Josephine J ^a   Rafii, Shahin ^b   Rabbany, Sina Y ^b,c   Spector, Jason A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c HOFSTRA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CELL MARKER; MOLECULAR SCAFFOLD; STROMAL CELL DERIVED FACTOR 1; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INVASION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENDOTHELIUM CELL; HYDROGEL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; WOUND CLOSURE; WOUND HEALING;

ANIMALS; ANTIGENS, CD; CADHERINS; CELL CULTURE TECHNIQUES; CHEMOKINE CXCL12; DRUG DELIVERY SYSTEMS; HYDROGEL; MALE; MICE; MICE, INBRED C57BL; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VON WILLEBRAND FACTOR; WOUND HEALING;

EID: 79955743145     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00687.x     Document Type: Article

References (23)

1. Riedel K, Ryssel H, Koellensperger E, Germann G, Kremer T. Pathogenesis of chronic wounds. Chirurg 2008; 79: 526-34.
2. Medina A, Scott PG, Ghahary A, Tredget EE. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil 2005; 26: 306-19. (Pubitemid 41074514)
3. Mustoe TA, O'Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 2006; 117: 35S-41S.
4. Schantz JT, Chim H, Whiteman M. Cell guidance in tissue engineering: SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactone scaffolds. Tissue Eng 2007; 13: 2615-24. (Pubitemid 350076752)
5. Kim KL, Han DK, Park K, Song SH, Kim JY, Kim JM, Ki HY, Yie SW, Roh CR, Jeon ES, Kim DK, Suh W. Enhanced dermal wound neovascularization by targeted delivery of endothelial progenitor cells using an RGD-g-PLLA scaffold. Biomaterials 2009; 30: 3742-8.
6. Rabbany SY, Pastore J, Yamamoto M, Miller T, Rafii S, Aras R, Penn M. Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant 2010; 19: 399-408.
7. Dittrich R, Despang F, Bernhardt A, Mannschatz A, Hanke TH, Tomandl G, Pompe W, Gelinsky M. Mineralized scaffolds for hard tissue engineering by ionotropicgelation of alginate. Adv Sci Technol 2006; 49: 159-64.
8. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Guide for the care and use of laboratory animals. Washington: National Academy Press, 1996.
9. Galiano RD, Michaels J, Dobryansky M, Levine JP, Gurtner GC. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 2004; 12: 485-92. (Pubitemid 39007049)
10. Menke NB, Ward KR, Witten TM, Bonchev DG, Digelmann RF. Impaired wound healing. Clin Dermatol 2007; 25: 19-25. (Pubitemid 46177472)
11. Whitney JD. Overview: acute and chronic wounds. Nurs Clin North Am 2005; 40: 191-205. (Pubitemid 40744980)
12. Misra P, Lebeche D, Ly H, Schwarzkopf D, Diaz G, Hajjar RJ, Schecter AD, Frangioni JV. Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha. J Nucl Med 2008; 49: 964-9.
13. Lui ZJ, Velazquez OC. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008; 10: 1869-82.
14. Li B, Davidson JM, Guelcher SA. The effect of the local delivery of platelet-derived growth factor reactive two-component polyurethane scaffolds in the healing in rat skin excisional wounds. Biomaterials 2009; 30: 3486-94.
15. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B, Hattori K, Zhang F, Hicklin DJ, Wu Y, Zhu Z, Dunn A, Salari H, Werb Z, Hackett NR, Crystal RG, Lyden D, Rafii S. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006; 12: 557-67.
16. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007; 28: 299-307. (Pubitemid 46963141)
17. Chen T, Bai H, Shao Y, Arzigian M, Janzen V, Attar E, Xie Y, Scadden DR, Wang ZZ. Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro. Stem Cells 2007; 25: 392-401. (Pubitemid 46232794)
18. Badillo AT, Chung S, Zhang L, Zoltick P, Liechty KW. Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing. J Surg Res 2007; 143: 35-42. (Pubitemid 47562443)
19. Gallaher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velezquez OC. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1-alpha. J Clin Invest 2007; 117: 1249-59. (Pubitemid 46718413)
20. Asnis LA, Gaspari AA. Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol 1995; 33: 393-410.
21. Dantzer R, Wollman EE, Yirmiya R. Cytokines, stress, and depression. New York, NY: Kluwer Academic/Plenum, 1999.
22. Crawford JM. Cellular and molecular biology of the inflamed liver. Curr Opin Gastroenterol 1997; 13: 175-85. (Pubitemid 27270318)
23. Jones A, Selby PJ, Viner C, Hobbs S, Gore ME, McElwain TJ. Tumor necrosis factor, cholestasis jaundice, and chronic liver disease. Gut 1990; 31: 938-9. (Pubitemid 20269548)